Medios AG | WebDisclosure

Basculer en Français

10375	Companies
216275	Keywords
145952	Articles
114497	Press releases

Home
Companies
Medios AG

PRESS RELEASE

published on 05/12/2025 at 18:58, 11 months 29 days ago

Medios repositions itself for the next phase of its corporate development
Medios AG announces changes in Executive Board as part of corporate development transition. Founder and CEO to step down, COO to leave company. Focus on profitability and value creation. Professional search for CEO successor initiated

Profitability Executive Board Medios AG Corporate Development CEO Successor
PRESS RELEASE

published on 05/12/2025 at 18:56, 11 months 29 days ago

EQS-Adhoc: Changes to the Medios AG Executive Board; Matthias Gärtner will leave the company
Medios AG announces changes to its Executive Board with Matthias Gärtner, CEO, and Mi-Young Miehler, COO, leaving the company under mutual agreement for an organized transition

Executive Board Supervisory Board Medios AG Matthias Gärtner Mi-Young Miehler
BRIEF

published on 03/25/2025 at 07:55, 1 year 1 month ago

Medios AG prévoit une croissance continue en 2025

Medios AG Prévisions De Revenus Augmentation De L'EBITDA Croissance 2025 Pharmaceutique Spécialisée
BRIEF

published on 03/25/2025 at 07:55, 1 year 1 month ago

Medios AG Projects Continued Growth in 2025

Revenue Forecast Medios AG EBITDA Increase Specialty Pharma 2025 Growth
PRESS RELEASE

published on 03/25/2025 at 07:50, 1 year 1 month ago

Medios expects further growth in revenue and earnings after record year 2024
Medios expects further growth in revenue and earnings after a record year in 2024. Consolidated revenue up 5.5% to €1.9 billion. EBITDA pre1 margin reaches 4.2%. Positive outlook for 2025 with revenue expected to reach €2.0 billion

Revenue Growth Earnings Forecast Record Year Medios 2025 Outlook
BRIEF

published on 03/04/2025 at 08:55, 1 year 2 months ago

Medios AG Reports Strong Earnings Growth in 2024, Eyes Further Gains in 2025

Pharmaceutical Industry Medios AG Financial Growth 2024 Results 2025 Outlook
BRIEF

published on 03/04/2025 at 08:55, 1 year 2 months ago

Medios AG annonce une forte croissance de ses bénéfices en 2024 et prévoit de nouveaux gains en 2025

Croissance Financière Medios AG Résultats 2024 Industrie Pharmaceutique Perspectives 2025
PRESS RELEASE

published on 03/04/2025 at 08:50, 1 year 2 months ago

Preliminary figures for Medios AG 2024: Significant increase in earnings and margins – positive outlook for 2025
Medios AG reports significant increase in earnings and margins for 2024, positive outlook for 2025. Preliminary figures show revenue reaching €1.9 billion and EBITDA pre1 around €79 million

Revenue Outlook Earnings Medios AG Margins
BRIEF

published on 12/12/2024 at 13:32, 1 year 4 months ago

Medios AG ajuste ses prévisions financières pour l'ensemble de l'année

Medios AG Prévisions Financières Marge D'EBITDA Augmentation Des Revenus Spécialité Pharmaceutique
BRIEF

published on 12/12/2024 at 13:32, 1 year 4 months ago

Medios AG Adjusts Full-Year Financial Forecast

Revenue Increase EBITDA Margin Financial Forecast Medios AG Specialty Pharma

Accesswire

Published on 05/11/2026 at 08:05, 57 minutes ago

Tocvan Accelerates Gran Pilar: 5,000+ Meters Drilled to Date, Historic Workings Discovered on South Block, Pilot Progresses
Published on 05/09/2026 at 01:55, 2 days 7 hours ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 2 days 7 hours ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 2 days 7 hours ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 2 days 9 hours ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology

View all ACCESSWIRE

EQS Group

Published on 05/11/2026 at 08:40, 22 minutes ago

ZPMC Renews "Shanghai Brand" Certificate No. 001 for 3E-Class Ship-to-Shore Cranes
Published on 05/11/2026 at 08:30, 32 minutes ago

Viromed Medical AG: ViroCAP® med successfully completes regulatory process as a Class IIa medical device – starting signal for market launch at the European Wound Congress 2026
Published on 05/11/2026 at 08:30, 32 minutes ago

Eurobattery Minerals secures SEK 60 million convertible bond facility and draws first tranche of SEK 10 million
Published on 05/11/2026 at 08:30, 32 minutes ago

2G Energy AG has rescheduled the release of preliminary figures for mid-June 2026. ERP closing procedures at the newly established production company are taking longer than planned.
Published on 05/11/2026 at 08:05, 57 minutes ago

SWI Capital - Convocation of annual general meeting of shareholders

Les Echos

Published on 05/07/2026 at 19:15, 3 days 13 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 13 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 13 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 13 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 14 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE